Page 14 - Read Online
P. 14
Page 311 Zhang et al. J Transl Genet Genom 2024;8:302-11 https://dx.doi.org/10.20517/jtgg.2024.39
44. Battaglia Y, Bulighin F, Zerbinati L, Vitturi N, Marchi G, Carraro G. Dapaglifozin on albuminuria in chronic kidney disease patients
with Fabry disease: the DEFY study design and protocol. J Clin Med 2023;12:3689. DOI PubMed PMC
45. Romagnani P, Lasagni L, Remuzzi G. Renal progenitors: an evolutionary conserved strategy for kidney regeneration. Nat Rev Nephrol
2013;9:137-46. DOI PubMed
46. Huang B, Zeng Z, Kim S, et al. Long-term expandable mouse and human-induced nephron progenitor cells enable kidney organoid
maturation and modeling of plasticity and disease. Cell Stem Cell 2024;31:921-39.e17. DOI PubMed PMC
47. Lasagni L, Angelotti ML, Ronconi E, et al. Podocyte regeneration driven by renal progenitors determines glomerular disease remission
and can be pharmacologically enhanced. Stem Cell Reports 2015;5:248-63. DOI PubMed PMC
48. Ugalde-Altamirano J, Juarez JR, Tubita V, et al. #2908 renal progenitor cells an early non-invasive biomarker of silent kidney injury in
Fabry disease. Nephrol Dial Transpl 2024;5:gfae069-0003-2908. DOI
